We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $2.7B
1-Year Est. Return 37.16%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+37.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
–
Cap. Flow
+$182M
Cap. Flow %
103.15%
Top 10 Hldgs %
87.49%
Holding
21
New
21
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$43.9M
2
ETR icon
Entergy
ETR
+$16.5M
3
SARO
StandardAero Inc
SARO
+$15.3M
4
AEP icon
American Electric Power
AEP
+$15.2M
5
VIK icon
Viking Holdings
VIK
+$14M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 24.79%
2 Utilities 18.96%
3 Industrials 14.8%
4 Healthcare 11.59%
5 Consumer Discretionary 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
1
Charles Schwab
SCHW
$177B
$43.8M 24.79%
+559,300
New +$43.9M
ETR icon
2
Entergy
ETR
$54.1B
$17.1M 9.68%
+200,000
New +$16.5M
AEP icon
3
American Electric Power
AEP
$73.7B
$16.4M 9.28%
+150,000
New +$15.2M
SARO
4
StandardAero Inc
SARO
$9.54B
$15.3M 8.67%
+575,000
New +$15.3M
KKR.PRD
5
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.21B
$13M 7.34%
+262,500
New +$12.9M
VIK icon
6
Viking Holdings
VIK
$44.9B
$12.1M 6.84%
+303,723
New +$14M
WAY
7
Waystar Holding Corp
WAY
$4.32B
$11.7M 6.65%
+314,300
New +$12.4M
ADT icon
8
ADT
ADT
$5.16B
$9.97M 5.65%
+1,225,151
New +$9.25M
SFD
9
Smithfield Foods
SFD
$10.3B
$8.58M 4.86%
+420,915
New +$8.6M
SAIL
10
SailPoint Inc
SAIL
$8.48B
$6.57M 3.72%
+350,365
New +$7.63M
VG
11
Venture Global Inc
VG
$35.6B
$5.79M 3.28%
+561,695
New +$8.19M
BBNX
12
Beta Bionics
BBNX
$706M
$3.38M 1.91%
+275,825
New +$5.14M
RACE icon
13
Ferrari
RACE
$63.3B
$3.22M 1.83%
+7,534
New +$3.39M
PRMB
14
Primo Brands
PRMB
$8.24B
$2.71M 1.53%
+76,281
New +$2.49M
BTSG icon
15
BrightSpring Health Services
BTSG
$14.3B
$1.81M 1.02%
+99,973
New +$1.96M
NPCE icon
16
Neuropace
NPCE
$505M
$1.23M 0.7%
+99,985
New +$1.25M
BNTC icon
17
Benitec Biopharma
BNTC
$394M
$1.04M 0.59%
+80,000
New +$968K
AKBA icon
18
Akebia Therapeutics
AKBA
$327M
$960K 0.54%
+500,000
New +$1.02M
KRMN
19
Karman Holdings
KRMN
$6.29B
$836K 0.47%
+25,000
New +$807K
TTAM
20
Titan America SA
TTAM
$3.16B
$811K 0.46%
+60,000
New +$887K
KMTS
21
Kestra Medical Technologies
KMTS
$1.23B
$314K 0.18%
+12,600
New +$290K

Similar funds

GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $2.7B AUM 23.82% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
CI
Capital International Los Angeles, California $2.7B AUM 31.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return
HC
Henshaw Capital Woburn, Massachusetts $2.7B AUM 29.67% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return

Longaeva Partners's Q1 2025 Portfolio in Review

Q1 2025 is the first quarter with a 13F filing on record for Longaeva Partners, which disclosed 21 positions worth $177M. Its ten largest holdings account for 87% of the portfolio.

Its largest position is Charles Schwab: 559,300 shares worth $43.8M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, followed by Utilities and Industrials.

  • Longaeva Partners's largest Q1 2025 buy was Charles Schwab: 559,300 shares worth $43.8M.
  • Longaeva Partners's ten largest holdings make up 87% of its $177M portfolio in Q1 2025.
  • Longaeva Partners disclosed 21 positions in Q1 2025, its first 13F filing on record.

Based on Longaeva Partners's 13F filing for Q1 2025, filed 15 May 2025.